scholarly journals P005 Cytokine mediated intercellular communication in inflammatory bowel disease

2021 ◽  
Vol 15 (Supplement_1) ◽  
pp. S127-S128
Author(s):  
J P Thomas ◽  
M Olbei ◽  
I Hautefort ◽  
D Modos ◽  
T Korcsmaros

Abstract Background During inflammatory bowel disease the mucosal immune system is altered. The mucosal immune cells are communicating through the various cytokines. Single cell and small volume RNA-seq and proteomics approaches make the investigation of cytokine networks plausible However the lack of specific resources make such efforts hard. Methods To address this need in this project, we built a cell-cell communication map, CytokineLink, which collates cytokine mediated intercellular interactions. CytokineLink collects the cytokine-cytokine receptor interactions from the OmniPath, immuneXpresso and immunoGlobe databases. We demonstrate the applicability of CytokineLink by presenting how cytokine feedback loops are built and altered during Ulcerative Colitis. We mapped single-cell RNA-seq expression data from inflamed and uninflamed Ulcerative Colitis biopsies to the interactions between cytokines and cytokine receptors, and then we compared the specific cytokine-mediated cell-cell interactions. Results Using our approach, we were able to point out major differences in cell-cell communication between inflamed and uninflamed conditions, and identify key cytokine changes. For example, the generally anti-inflammatory cytokine IL-10 is produced by regulatory T-cells in both conditions. However the IL-10 receptor positive cells are altered between the inflamed and uninflamed condition: dendritic cells and innate lymphocytes did not express the receptor in the sufficient amount. It suggests that not the cytokine level directly but the receptor level alterations are involved in ulcerative colitis. Also the chemokine CXCL12 was expressed by the inflammatory fibroblasts. This cytokine promotes the T-cell recruitment and through that inflammation. Conclusion With CytokineLink, researchers are capable to pinpoint the most important interactions in the changing mucosal immune system and propose novel therapeutic approaches. We are currently developing a website and easy to follow workflows to make CytokineLink available.

2011 ◽  
Vol 33 (4) ◽  
pp. 26-31
Author(s):  
Mona Bajaj-Elliott

Intestinal homoeostasis is a complex affair. We are just beginning to appreciate the molecular nature of the crosstalk that allows happy coexistence between the commensal resident microbiota and the gastrointestinal (GI) mucosal immune system. Both microbial and host components involved in this interplay are being increasingly identified and studied. A better understanding of these multifaceted interactions holds the key for unlocking the cellular events responsible for gut inflammatory conditions such as Crohn's disease and ulcerative colitis.


2019 ◽  
Vol 25 (5) ◽  
pp. 811-815 ◽  
Author(s):  
Mariana X Byndloss ◽  
Yael Litvak ◽  
Andreas J Bäumler

An imbalance in our microbiota may contribute to many human diseases, but the mechanistic underpinnings of dysbiosis remain poorly understood. We argue that dysbiosis is secondary to a defect in microbiota-nourishing immunity, a part of our immune system that balances the microbiota to attain colonization resistance against environmental exposure to microorganisms. We discuss this new hypothesis and its implications for ulcerative colitis, an inflammatory bowel disease of the large intestine.


Physiology ◽  
2001 ◽  
Vol 16 (6) ◽  
pp. 272-277 ◽  
Author(s):  
F. Stephen Laroux ◽  
Kevin P. Pavlick ◽  
Robert E. Wolf ◽  
Matthew B. Grisham

The mucosal interstitia of the intestine and colon are continuously exposed to large amounts of dietary and microbial antigens. Fortunately, the mucosal immune system has evolved efficient mechanisms to distinguish potentially pathogenic from nonpathological antigens. There are, however, situations in which this immune regulation fails, resulting in chronic gut inflammation.


2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Shunyu Yao ◽  
Zixi Zhao ◽  
Weijun Wang ◽  
Xiaolu Liu

The prevalence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), increases gradually worldwide in the past decades. IBD is generally associated with the change of the immune system and gut microbiota, and the conventional treatments usually result in some side effects. Bifidobacterium longum, as colonizing bacteria in the intestine, has been demonstrated to be capable of relieving colitis in mice and can be employed as an alternative or auxiliary way for treating IBD. Here, the mechanisms of the Bifidobacterium longum in the treatment of IBD were summarized based on previous cell and animal studies and clinical trials testing bacterial therapies. This review will be served as a basis for future research on IBD treatment.


2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S010-S011
Author(s):  
E Brand ◽  
Y Laenen ◽  
F van Wijk ◽  
M de Zoete ◽  
B Oldenburg

Abstract Background The pathogenesis of inflammatory bowel disease (IBD) is thought to result from an interplay between microbiota, the immune system and the environment in genetically susceptible hosts. Immunoglobulin A (IgA) produced by the immune system can be specifically directed against bacteria. The IgA-coating pattern of intestinal bacteria thus reflects interactions between the immune system and specific bacteria. Studying IBD in twins, concordant and discordant for IBD, reduces the impact of genetic predisposition and childhood exposures and therefore offers the unique opportunity to focus on other factors such as intestinal microbiota composition and immune-interactions in IBD. Methods Faecal samples from twin pairs discordant for Crohn’s disease (CD) or ulcerative colitis (UC) were collected. Employing fluorescence-activated cell sorting, IgA+ and IgA− bacteria from the intestinal microbiota were sorted. Subsequently, (1) the total, (2) IgA+ and (3) IgA− microbial composition was determined by 16S rRNA sequencing (IgA-SEQ). We estimated the relative IgA coating per bacterial species by dividing the abundance of that species in the IgA+ fraction over the abundance in the IgA- fraction, representing the IgA coating index. Linear discriminant analyses were performed with LefSE. Results We included 31 twin pairs (62 individuals) discordant for IBD (CD: 15, UC: 16). 15/32 twin pairs were monozygotic, 43/62 of participants were female, the median age was 47 years (interquartile range: 34–58.5). Of 31 participants with IBD, 7 had signs of active inflammation based on endoscopy, Harvey–Bradshaw index or short clinical colitis activity index. Differences (log-linear discriminant analysis score >3) in the microbial composition of IgA-coated bacteria were observed between CD patients and their twin-siblings not affected by IBD: Dorea formicigenerans (increased in IgA coating), Parabacteroides sp., Christensenellaceae sp., Clostridium sp. and Mollicutes RF39 sp. (decreased in IgA coating). In ulcerative colitis patients, an increase in IgA-coating was observed for Ruminococcus gnavus and Dorea formicigenerans, while Turicibacter sp., Barnesiellaceae sp. and an unclassified Clostridiales sp. were decreased in IgA-coating compared with their twin-siblings not affected by IBD. Conclusion In twins affected by IBD, the pattern of IgA-coated bacteria differs between IBD and non-IBD affected individuals. These data on immune-bacteria interactions could serve as a starting point for the elucidation of the immune-responses triggered by specific bacteria in IBD.


2021 ◽  
Vol 8 ◽  
Author(s):  
Ning Liu ◽  
Gang Feng ◽  
Xiaoying Zhang ◽  
Qingjuan Hu ◽  
Shiqiang Sun ◽  
...  

Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is one of the main types of intestinal inflammatory diseases with intestine mucosal immune disorder. Intestine mucosal immune system plays a remarkable and important role in the etiology and pathogenesis of IBD. Therefore, understanding the intestine mucosal immune mechanism is a key step to develop therapeutic interventions for IBD. Intestine mucosal immune system and IBD are influenced by various factors, such as inflammation, gut permeability, gut microbiota, and nutrients. Among these factors, emerging evidence show that nutrients play a key role in inflammation activation, integrity of intestinal barrier, and immune cell modulation. Lactoferrin (LF), an iron-binding glycoprotein belonging to transferrin family, is a dietary bioactive component abundantly found in mammalian milk. Notably, LF has been reported to perform diverse biological functions including antibacterial activity, anti-inflammatory activity, intestinal barrier protection, and immune cell modulation, and is involved in maintaining intestine mucosal immune homeostasis. The improved understanding of the properties of LF in intestine mucosal immune system and IBD will facilitate its application in nutrition, clinical medicine, and health. Herein, this review outlines the recent advancements on LF as a potential therapeutic intervention for IBD associated with intestine mucosal immune system dysfunction. We hope this review will provide a reference for future studies and lay a theoretical foundation for LF-based therapeutic interventions for IBD by understanding the particular effects of LF on intestine mucosal immune system.


Sign in / Sign up

Export Citation Format

Share Document